Chase Knickerbocker
Stock Analyst at Craig-Hallum
(4.96)
# 112
Out of 5,074 analysts
656
Total ratings
54.6%
Success rate
33.7%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals | Reiterated: Buy | $20 → $15 | $7.01 | +113.98% | 36 | Oct 21, 2026 | |
| GUTS Fractyl Health | Reiterated: Buy | $48 → $5 | $1.13 | +342.48% | 4 | Oct 19, 2026 | |
| MDXG MiMedx Group | Reiterated: Buy | n/a | $3.93 | - | 46 | Oct 1, 2026 | |
| HROW Harrow | Reiterated: Buy | n/a | $28.15 | - | 46 | Sep 29, 2026 | |
| NRXS NeurAxis | Reiterated: Buy | n/a | $7.60 | - | 14 | Sep 29, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $12 | $10.86 | +10.50% | 31 | Sep 29, 2026 | |
| TELA TELA Bio | Initiated Coverage: Buy | $2 | $1.01 | +98.02% | 1 | Sep 25, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Hold | n/a | $1.37 | - | 31 | Sep 22, 2026 | |
| MDWD MediWound | Reiterated: Buy | n/a | $12.18 | - | 16 | Sep 22, 2026 | |
| INDV Indivior Pharmaceuticals | Reiterated: Buy | n/a | $35.33 | - | 39 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $6.81 | +46.84% | 25 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $178 → $173 | $65.57 | +163.84% | 29 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.91 | +109.42% | 20 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $8.31 | +104.57% | 5 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $76 | $50.02 | +51.94% | 39 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 | $10.32 | +74.42% | 34 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $0.6 | $0.312 | +92.31% | 38 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $14.75 | +62.71% | 28 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $18 | $15.04 | +19.68% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.08 | +95.12% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.1 → $1.7 | $1.22 | +39.34% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.13 | +133.92% | 19 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.57 | - | 33 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.69 | - | 1 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.27 | - | 1 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.63 | - | 24 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $56.73 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $125.12 | - | 1 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $65.28 | n/a | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $27.01 | n/a | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $307.82 | n/a | 3 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $59.69 | n/a | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.87 | n/a | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $55.65 | n/a | 1 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.05 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $10.92 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.09 | n/a | 1 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $37.09 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $15.95 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $8.76 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.78 | n/a | 1 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $4.76 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $0.8327 | n/a | 1 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $22.45 | n/a | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $14.14 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $35.14 | n/a | 1 | May 3, 2023 |
Phathom Pharmaceuticals
Oct 21, 2026
Reiterated: Buy
Price Target: $20 → $15
Current: $7.01
Upside: +113.98%
Fractyl Health
Oct 19, 2026
Reiterated: Buy
Price Target: $48 → $5
Current: $1.13
Upside: +342.48%
MiMedx Group
Oct 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.93
Upside: -
Harrow
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $28.15
Upside: -
NeurAxis
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.60
Upside: -
Xeris Biopharma Holdings
Sep 29, 2026
Reiterated: Buy
Price Target: $12
Current: $10.86
Upside: +10.50%
TELA Bio
Sep 25, 2026
Initiated Coverage: Buy
Price Target: $2
Current: $1.01
Upside: +98.02%
CVRx, Inc.
Sep 22, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.37
Upside: -
MediWound
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.18
Upside: -
Indivior Pharmaceuticals
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.33
Upside: -
Sep 2, 2026
Reiterated: Buy
Price Target: $10
Current: $6.81
Upside: +46.84%
Aug 18, 2026
Reiterated: Buy
Price Target: $178 → $173
Current: $65.57
Upside: +163.84%
Aug 18, 2026
Reiterated: Buy
Price Target: $4
Current: $1.91
Upside: +109.42%
Aug 14, 2026
Reiterated: Buy
Price Target: $17
Current: $8.31
Upside: +104.57%
Aug 14, 2026
Reiterated: Buy
Price Target: $62 → $76
Current: $50.02
Upside: +51.94%
Aug 12, 2026
Rated: Buy
Price Target: $18
Current: $10.32
Upside: +74.42%
Aug 12, 2026
Rated: Buy
Price Target: $0.6
Current: $0.312
Upside: +92.31%
Aug 7, 2026
Reiterated: Buy
Price Target: $24
Current: $14.75
Upside: +62.71%
Aug 6, 2026
Rated: Buy
Price Target: $16 → $18
Current: $15.04
Upside: +19.68%
Aug 6, 2026
Reiterated: Buy
Price Target: $6
Current: $3.08
Upside: +95.12%
Aug 6, 2026
Reiterated: Buy
Price Target: $1.1 → $1.7
Current: $1.22
Upside: +39.34%
Jul 22, 2026
Reiterated: Buy
Price Target: $12
Current: $5.13
Upside: +133.92%
Jul 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.57
Upside: -
Jul 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.69
Upside: -
Jun 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.27
Upside: -
Jun 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.63
Upside: -
Nov 20, 2025
Reiterated: Buy
Price Target: n/a
Current: $56.73
Upside: -
Nov 19, 2025
Reiterated: Buy
Price Target: n/a
Current: $125.12
Upside: -
Oct 20, 2025
Reiterated: Buy
Price Target: n/a
Current: $65.28
Upside: n/a
Oct 17, 2025
Rated: Hold
Price Target: n/a
Current: $27.01
Upside: n/a
Oct 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $307.82
Upside: n/a
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $59.69
Upside: n/a
Jul 23, 2025
Rated: Hold
Price Target: n/a
Current: $1.87
Upside: n/a
Jul 22, 2025
Reiterated: Buy
Price Target: n/a
Current: $55.65
Upside: n/a
Jul 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $9.05
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: $12
Current: $10.92
Upside: n/a
Feb 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.09
Upside: n/a
Aug 28, 2024
Rated: Buy
Price Target: n/a
Current: $37.09
Upside: n/a
Aug 1, 2024
Reiterated: Buy
Price Target: $38
Current: $15.95
Upside: n/a
Jul 18, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $8.76
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $10
Current: $4.78
Upside: n/a
Oct 16, 2023
Rated: Buy
Price Target: n/a
Current: $4.76
Upside: n/a
Sep 13, 2023
Rated: Buy
Price Target: n/a
Current: $0.8327
Upside: n/a
Aug 18, 2023
Rated: Buy
Price Target: n/a
Current: $22.45
Upside: n/a
May 4, 2023
Rated: Buy
Price Target: n/a
Current: $14.14
Upside: n/a
May 3, 2023
Rated: Buy
Price Target: $58
Current: $35.14
Upside: n/a